Research News

Line of women in profile, chins pronounced.
  • Keep your chin up
    2/18/26

    A UB-led study shows that the chin is an evolutionary accident.

  • AAAS fellows
    11/30/15

    UB researchers Luis A. Colón and Mark T. Swihart have been named fellows of the American Association for the Advancement of Science.

  • Fueling terrorism
    11/20/15

    Social Work professor Hilary Weaver says preventing Syrian refugees from entering the U.S. would fuel, not curb, terrorism.

  • Unintended consequences from tight security
    11/19/15

    Security measures in American high schools can have unintended consequences that hinder, rather than help students learn, according to new UB and Canisius College research.

  • False Positive
    11/19/15

    Performance art created by UB faculty member Mark Shepard raises awareness of online privacy issues.

  • Addressing pediatric obesity
    11/19/15

    New UB faculty member Carroll McWilliams Harmon, co-author of a national teen weight-loss surgery study, brings a fresh perspective to Western New York’s pediatric obesity problem.

  • Helping nanoparticle glow
    11/19/15

    A new, onion-like nanoparticle developed by a UB research team could open new frontiers in biomaging, solar energy harvesting and light-based security techniques.

  • Bad for business
    11/19/15

    A study by School of Management faculty member Veljko Fotak has found that returns are weaker for investments made by highly politicized government-owned investment funds.

  • Through the looking glass
    11/12/15

    Architecture faculty members Georg Rafailidis and Stephanie Davidson have launched a material investigation in search of new expressions for glass in and as architecture.

  • Fulbright recipient
    11/12/15

    UB geographer Chris Renschler has received a prestigious Fulbright Scholar award to conduct research and lecture in Austria.

  • Worm's behavior yields clue
    11/12/15

    A mutant worm's reaction to a foul smell could lead to new treatment avenues for diseases ranging from schizophrenia to Parkinson’s.